Assessment of remission maintenance effect of leukocytapheresis for ulcerative colitis
- Conditions
- lcerative colitis
- Registration Number
- JPRN-UMIN000008905
- Lead Sponsor
- Tokai University Hachioji Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Not provided
1. Patients under 18 y.o. 2. Patients with either white blood cell count of less than 3,000/mm3, or platelet count of less than 100,000/mm3. 3. Patients with allergic anamnesis or experience or the fear of allergic hypersensitivity reaction. 4. Patients with serious infection or cardiovascular disease or liver disease or kidney disease or respiratory disease or metabolic disease neurologic disease. 5. Patients having received inhibitor of angiotensin converting enzyme. 6. Patients with hypotension (less than maximal blood pressure 80mmHg) 7. Patients who are pregnant or possibly pregnant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of remission maintained (days)
- Secondary Outcome Measures
Name Time Method